"The RDIF is in constant contact with the World Health Organisation. An application has also been submitted for participation in the COVAX programme", Primak said during a conference on perspectives of Sputnik V in Europe.
RDIF CEO Kirill Dmitriev said that the fund will be cooperating with COVAX but would prioritise vaccine deliveries to countries directly. Sputnik V has already been approved for use in 55 countries, ranking second worldwide in terms of the number of approvals.
COVAX is an international mechanism launched by the World Health Organisation to support the equitable distribution of coronavirus vaccines to low-income countries.